Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 20 studies | 35% ± 12% | |
| astrocyte | 17 studies | 34% ± 19% | |
| fibroblast | 16 studies | 34% ± 14% | |
| macrophage | 15 studies | 40% ± 19% | |
| oligodendrocyte | 15 studies | 41% ± 16% | |
| ciliated cell | 14 studies | 36% ± 16% | |
| microglial cell | 13 studies | 47% ± 12% | |
| oligodendrocyte precursor cell | 11 studies | 36% ± 14% | |
| GABAergic neuron | 10 studies | 44% ± 25% | |
| glutamatergic neuron | 10 studies | 51% ± 25% | |
| pericyte | 10 studies | 32% ± 12% | |
| myeloid cell | 9 studies | 33% ± 13% | |
| adipocyte | 9 studies | 33% ± 10% | |
| type I pneumocyte | 8 studies | 43% ± 19% | |
| epithelial cell | 8 studies | 38% ± 18% | |
| smooth muscle cell | 8 studies | 32% ± 11% | |
| classical monocyte | 6 studies | 22% ± 6% | |
| non-classical monocyte | 6 studies | 24% ± 9% | |
| neuron | 6 studies | 37% ± 19% | |
| interneuron | 6 studies | 49% ± 28% | |
| dendritic cell | 6 studies | 28% ± 6% | |
| mast cell | 6 studies | 28% ± 12% | |
| endothelial cell of lymphatic vessel | 6 studies | 31% ± 7% | |
| plasma cell | 5 studies | 32% ± 10% | |
| cardiac muscle cell | 5 studies | 43% ± 13% | |
| mesothelial cell | 5 studies | 33% ± 12% | |
| monocyte | 5 studies | 48% ± 12% | |
| club cell | 5 studies | 31% ± 11% | |
| type II pneumocyte | 5 studies | 39% ± 8% | |
| basal cell | 5 studies | 33% ± 20% | |
| granule cell | 4 studies | 26% ± 6% | |
| B cell | 4 studies | 22% ± 6% | |
| amacrine cell | 4 studies | 23% ± 9% | |
| retina horizontal cell | 4 studies | 25% ± 10% | |
| retinal cone cell | 4 studies | 24% ± 9% | |
| retinal rod cell | 4 studies | 30% ± 6% | |
| muscle cell | 4 studies | 31% ± 23% | |
| goblet cell | 4 studies | 37% ± 27% | |
| hepatic stellate cell | 3 studies | 44% ± 21% | |
| GABAergic interneuron | 3 studies | 35% ± 2% | |
| glial cell | 3 studies | 27% ± 5% | |
| mononuclear phagocyte | 3 studies | 31% ± 8% | |
| Mueller cell | 3 studies | 30% ± 9% | |
| glycinergic amacrine cell | 3 studies | 24% ± 6% | |
| hepatocyte | 3 studies | 59% ± 15% | |
| retinal pigment epithelial cell | 3 studies | 32% ± 21% | |
| abnormal cell | 3 studies | 28% ± 14% | |
| connective tissue cell | 3 studies | 32% ± 9% | |
| ependymal cell | 3 studies | 63% ± 8% | |
| alveolar macrophage | 3 studies | 51% ± 12% | |
| respiratory goblet cell | 3 studies | 34% ± 14% | |
| mucus secreting cell | 3 studies | 29% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1226.81 | 1445 / 1445 | 100% | 12.71 | 183 / 183 |
| lung | 100% | 1849.22 | 578 / 578 | 100% | 9.79 | 1154 / 1155 |
| brain | 100% | 1177.23 | 2636 / 2642 | 100% | 14.01 | 705 / 705 |
| prostate | 100% | 1342.50 | 245 / 245 | 99% | 9.22 | 499 / 502 |
| breast | 100% | 1305.83 | 459 / 459 | 99% | 8.86 | 1103 / 1118 |
| bladder | 100% | 1388.57 | 21 / 21 | 98% | 7.98 | 494 / 504 |
| intestine | 100% | 1389.78 | 966 / 966 | 98% | 8.45 | 516 / 527 |
| pancreas | 99% | 806.37 | 326 / 328 | 98% | 10.45 | 175 / 178 |
| stomach | 100% | 1240.28 | 359 / 359 | 98% | 10.38 | 279 / 286 |
| adrenal gland | 100% | 2458.92 | 258 / 258 | 97% | 6.45 | 222 / 230 |
| kidney | 100% | 930.51 | 89 / 89 | 96% | 6.99 | 864 / 901 |
| uterus | 100% | 1650.73 | 170 / 170 | 96% | 7.07 | 440 / 459 |
| ovary | 100% | 1098.94 | 180 / 180 | 96% | 5.43 | 411 / 430 |
| thymus | 100% | 1591.66 | 653 / 653 | 95% | 10.85 | 575 / 605 |
| liver | 100% | 1423.83 | 226 / 226 | 94% | 6.43 | 382 / 406 |
| skin | 100% | 1513.20 | 1808 / 1809 | 93% | 10.66 | 439 / 472 |
| adipose | 100% | 1515.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1966.43 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1054.35 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.30 | 1 / 1 |
| heart | 99% | 1156.82 | 850 / 861 | 0% | 0 | 0 / 0 |
| muscle | 96% | 545.50 | 774 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 5.69 | 42 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 79% | 3.91 | 23 / 29 |
| eye | 0% | 0 | 0 / 0 | 56% | 3.36 | 45 / 80 |
| peripheral blood | 51% | 227.61 | 478 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0042147 | Biological process | retrograde transport, endosome to Golgi |
| GO_0051301 | Biological process | cell division |
| GO_1902017 | Biological process | regulation of cilium assembly |
| GO_0043547 | Biological process | positive regulation of GTPase activity |
| GO_0090630 | Biological process | activation of GTPase activity |
| GO_0005813 | Cellular component | centrosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005819 | Cellular component | spindle |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0031267 | Molecular function | small GTPase binding |
| GO_0005096 | Molecular function | GTPase activator activity |
| Gene name | EVI5 |
| Protein name | Ecotropic viral integration site 5 Ecotropic viral integration site 5 protein homolog (EVI-5) (Neuroblastoma stage 4S gene protein) |
| Synonyms | NB4S |
| Description | FUNCTION: Functions as a regulator of cell cycle progression by stabilizing the FBXO5 protein and promoting cyclin-A accumulation during interphase. May play a role in cytokinesis. . |
| Accessions | ENST00000540033.3 [O60447-2] ENST00000706845.1 ENST00000706868.1 ENST00000706867.1 ENST00000706846.1 A0A9L9PXM6 ENST00000706847.1 A0A9L9PXL1 ENST00000370331.5 [O60447-1] A0A804HIC4 O60447 A0A9L9PXL6 ENST00000684568.2 A0A9L9PXD7 ENST00000706883.1 ENST00000706843.1 A0A9L9PYF1 A0A9L9PXE3 ENST00000706885.1 A0A9L9PYE8 |